1.A four-point clinical criteria distinguishes immune thrombocytopenia from acute lymphoblastic leukaemia
Su Han Lum ; Shi Jie How ; Hany Ariffin ; Shekhar Krishnan
The Medical Journal of Malaysia 2016;71(1):28-29
Immune thrombocytopenia is the most common diagnosis
of isolated thrombocytopenia. The dilemma encountered by
paediatricians is missing diagnosis of acute leukaemia in
children with isolated thrombocytopenia. We demonstrated
childhood ITP could be diagnosed using a four point clinical
criteria without missing a diagnosis of acute leukaemia.
Hence, bone marrow examination is not necessary in
children with typical features compatible with ITP prior to
steroid therapy. This can encourage paediatricians to
choose steroid therapy, which is cheaper and non-blood
product, as first line platelet elevating therapy in children
with significant haemorrhage.
Thrombocytopenic
3.Idiopathic Thrombocytopenic Purpura.
Journal of the Korean Pediatric Society 2001;44(2):115-118
No abstract available.
Purpura, Thrombocytopenic, Idiopathic*
4.A Clinico-Epidemilological Study of 55 Cases of Chidhood Idiopathic Thrombocytopenic Purpura.
Won Ho KANG ; Myung Hee KOOK ; Yong Sang YOO ; Jae Suk MA ; Tai Ju HWANG
Journal of the Korean Pediatric Society 1987;30(11):1207-1212
No abstract available.
Purpura, Thrombocytopenic, Idiopathic*
5.A Case of Thrombotic Thrombocytopenic Purpura in Childhood.
Dong Kun HYUN ; Jung Bae LEE ; Chang Hyun YANG ; Kir Young KIM
Journal of the Korean Pediatric Society 1988;31(4):511-518
No abstract available.
Purpura, Thrombotic Thrombocytopenic*
6.Dapsone therapy for immune thrombocytopenic purpura: old but still unfamiliar.
Blood Research 2017;52(2):77-78
No abstract available.
Dapsone*
;
Purpura, Thrombocytopenic, Idiopathic*
7.Successful treatment of steroid-refractory immune thrombocytopenia with alemtuzumab.
Chul Won JUNG ; Su Hee CHO ; Sylvia PARK ; Jun Ho JANG ; Jun Ho JI
Blood Research 2016;51(4):297-299
No abstract available.
Purpura, Thrombocytopenic, Idiopathic*
8.A case of rifampicin induced thrombocytopenic purpura.
Jin Hyoung WON ; Won HUR ; Sung Ku AHN ; Seung Hun LEE ; Kyung Joo LEE
Korean Journal of Dermatology 1991;29(6):817-821
No abstract available.
Purpura, Thrombocytopenic*
;
Rifampin*
9.Evaluation of the effects of splenectomy in treating chronic immuno thrombocytopenic purpurea
Journal of Vietnamese Medicine 2004;299(6):13-22
From Aug-2000 to Aug-2003 at HCM City Blood Transfusion and Hematology hospital, 31 cases of endoscopic splenectomy were studied to evaluate the effect of this surgery to treat chronical immuno-thrombocytopenic purpurea once corticotherapy and immunosupressive therapy failed. Results showed that one year after splenectomy, 64,52 – 76,92%, and 2 years after, 50% of cases had had completely positive response. There was absolute failure in 38,7% of cases within 3 first months, but from the 4th month, there was no relapse case. A half number of patients with failed splenectomy had had quick response to corticotherapy more.The duration of treatment was short, endoscopic splenectomy was safe. There was no death. No case of blood transfusion was needed. There were no complications
Splenectomy
;
Therapeutics
;
Purpura, Thrombocytopenic
10.Splenectomised by immuno thrombocytopenic purpura
Journal of Vietnamese Medicine 2001;263(9):13-16
The authors present a study on the pathological features of 45 spleens which were splenectomised by immune thrombocytopenic purpura (TTP) from 1/1/1990 to 31/12/1997 at Viet Duc hospital, 43/45 were women, age from 12 to 50, in which 35/45 were under 30 ages. Weight and sexe of these spleens were observed. They are in normal size or rather enlarged, but their weight are hyperplasis, but no sclerosis and nomalignacy: neutrophils, eosinophils, macrophages and sometimes megakaryocytes may be found in the red
Purpura, Thrombocytopenic
;
Pathology